Programa "Farmácia Popular do Brasil": caracterização e evolução entre 2004-2012

Silva, Rondineli Mendes da; Caetano, Rosângela

doi:10.1590/1413-812320152010.17352014

Cited by 47 publications

(29 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The FSUS provide the medicines considered essential, that is, those that meet the health needs of each location, municipality, or state. The FPFP also provide two sets of medicines: one with about 100 pharmaceutical products in the public network, another one more restricted and for the treatment of a group of NCD in the network of private pharmacies 24 , c , d .…”

Section: Discussionmentioning

confidence: 99%

“…As the number of pharmacies participating in the Popular Pharmacy Program is much higher than that of the public network, it is necessary to establish measures to ensure the quality of service to their users 9 , 24 .…”

Section: Discussionmentioning

confidence: 99%

“…Control of these diseases and of their risk factors depends on a set of health actions, which includes timely health care and adequate provision of medicines 16 . In Brazil, besides the private market supply, these medicines are available for free in public health services (SUS), including primary health care 7 and pharmacies of the Popular Pharmacy Program (FPFP) 24 . This program is a strategy to scaling up access, in which a set of medicines is supplied for free and another, broader, is sold at subsidized prices a .…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Access to medicines for chronic diseases in Brazil: a multidimensional approach

et al. 2016

View full text Add to dashboard Cite

OBJECTIVE To analyze the access to medicines to treat non-communicable diseases in Brazil according to socioeconomic, demographic, and health-related factors, from a multidimensional perspective.METHODS Analysis of data from the National Survey on Access, Use and Promotion of Rational Use of Medicines (PNAUM), household survey, sampling plan by conglomerates with representativeness of the Brazilian population and large areas of the country, according to sex and age domains. Data collected in 2013–2014 with sample of adults (≥ 20 years) who reported having non-communicable diseases and medical indication for use of medicines (n = 12,725). We assessed the prevalence of access to medicines for self-reported non-communicable diseases, considering four dimensions: availability, geographic accessibility, acceptability, and affordability. We applied Pearson’s Chi-square test to assess the statistical significance of the differences between strata, considering the level of significance of 5%. We found prevalence of 94.3%, 5.2%, and 0.5% for full, partial, and null access, respectively. Higher prevalence was observed among seniors in the South compared to the Northeast; for those who reported having one non-communicable disease compared to those who reported having two or more; for those who needed one medicine compared to those who needed three or more; and for those who self-assessed their health as good or very good. Geographic accessibility was similar in the Unified Health System and in the private pharmacies (72.0%). Total availability of medicines was 45.2% in the Unified Health System, 67.4% in the Popular Pharmacy Program, and 88.5% in private pharmacies. Acceptability was 92.5% in the Unified Health System, 97.8% in the Popular Pharmacy Program, and 98.7% in private pharmacies. As to affordability, 2.6% of the individuals failed to take the medicines they should in the 30-day period prior to the interview due to financial difficulty. Prevalence of full access to medicines for non-communicable diseases in Brazil is high and presents significant differences for age group, region of the country, number of non-communicable diseases, and for medicines prescribed and self-assessment of health. The major barriers to access to medicines were identified in the dimensions analyzed.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Access to medicines for chronic diseases in Brazil: a multidimensional approach

et al. 2016

View full text Add to dashboard Cite

show abstract

“…The Brazilian Popular Pharmacy Program was introduced in 2004 with its own pharmacy network and expanded in 2006 to the retail pharmacy network, called “ Aqui Tem Farmácia Popular ” (Popular Pharmacy Here). In 2004-2012, there was a significant increase in the number of accredited units (750.0%) and municipalities covered by the program (528.0%) 17 . Popular Pharmacy Program has been reported in some studies as an alternative due to the ready availability of medicines and prompt service, especially when the supply of medicines in public network pharmacies is irregular 6 , 16 .…”

Section: Discussionmentioning

confidence: 99%

Use of and access to oral and injectable contraceptives in Brazil

et al. 2016

View full text Add to dashboard Cite

OBJECTIVE To analyze the prevalence of current use of oral and injectable contraceptives by Brazilian women, according to demographic and socioeconomic variables and issues related to access to those medicines.METHODS A cross-sectional, population-based analytical study with probability sampling based on data from the Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM – National Survey on Access, Use and Promotion of Rational Use of Medicines), carried out between September 2013 and February 2014 in 20,404 Brazilian urban households. Prevalence was calculated based on reports from non-pregnant women aged 15-49 on the use of oral or injectable contraceptives. The independent variables were gender, age, level of education, socioeconomic class, Brazilian region and marital status. Also analyzed were access, means of payment, sources, and reported medicines. Statistical analyses considered 95% confidence intervals (95%CI) and Pearson Chi-square test to evaluate the statistical significance of differences between groups, considering a 5% significance level.RESULTS Prevalence of use was 28.2% for oral contraceptives (OC) and 4.5% for injectable contraceptives (IC). The highest prevalence of oral contraceptives was in the South region (37.5%) and the lowest in the North region (15.7%). For injectable contraceptives there was no difference between regions. Access was higher for oral contraceptive users (90.7%) than injectable contraceptives users (81.2%), as was direct payment (OC 78.1%, IC 58.0%). Users who paid for contraceptives acquired them at retail pharmacies (OC 95.0% and IC 86.6%) and at Farmácia Popular (Popular Pharmacy Program) (OC 4.8% and IC 12.7%). Free of charge contraceptives were mostly obtained from the Brazilian Unified Health System – SUS (OC 86.7%; IC 96.0%). Free samples were reported by 10.4% of users who did not pay for oral contraceptives. Most of paying users did not try to obtain contraceptives from SUS. Monophasic combined oral contraceptives were the most frequently reported (71.6%) and low-level levonorgestrel + ethinylestradiol combination accounted for 38.7% of them. The most frequently reported medicines are included in the Relação Nacional de Medicamentos Essenciais (RENAME – National List of Essential Medicines.CONCLUSIONS Most women aged 15 to 49 who reported using contraceptives had access to the medicine and use monophasic combined oral contraceptives of appropriate efficiency and safety purchased by direct payment, mainly from retail pharmacies.

show abstract

“…Ainda que os dispositivos legais norteadores do programa estabeleçam um conjunto de exigências sanitárias, particularmente a respeito de estrutura e presença de farmacêuti-co durante o horário de funcionamento das farmácias da rede própria ou credenciada, os estudos recentes realizados (SILVA;CAETANO, 2015), inclusive os resultados divulgados pelo próprio MS (BRASIL, 2014B), não apontam qualquer ênfase quanto à qualidade dos serviços dispensados nessas farmácias. Apesar da tendência de ampliação do programa, particularmente por meio do credenciamento de farmácias privadas ao 'Aqui tem Farmácia Popular', foi evidente uma inflexão, nos últimos anos, inclusive com reflexos na modalidade rede própria, havendo fechamento de unidades em todo o País.…”

Section: Mudanças E Desafios Para a Continuidade Do Pfpbunclassified

Reforma Sanitária Brasileira e políticas farmacêuticas: uma análise dos fatos produzidos entre 2003 e 2014

Alencar

Paim

2017

Saúde debate

View full text Add to dashboard Cite

RESUMO Estudo de caso cujo objetivo é analisar as políticas farmacêuticas do período de 2003 a 2014, tendo como referência a Reforma Sanitária Brasileira. As fontes de evidência foram documentos e entrevistas semiestruturadas, e o processamento dos dados ocorreu mediante a técnica da análise de conteúdo temática. Os dados obtidos foram organizados em dois momentos (períodos Lula e Dilma) e a análise foi fundamentada na teoria marxista. Os resultados indicam que a instituição das políticas farmacêuticas foi favorecida pela participação de atores sociais vinculados ao movimento sanitário no âmbito do Estado, o que permitiu uma reestruturação dessa agenda, ainda que mediante conflitos. PALAVRAS-CHAVE

show abstract

Programa "Farmácia Popular do Brasil": caracterização e evolução entre 2004-2012

Abstract: The "Farmácia Popular do Brasil" Program (PFPB)

Cited by 47 publications

References 12 publications

Access to medicines for chronic diseases in Brazil: a multidimensional approach

Access to medicines for chronic diseases in Brazil: a multidimensional approach

Use of and access to oral and injectable contraceptives in Brazil

Reforma Sanitária Brasileira e políticas farmacêuticas: uma análise dos fatos produzidos entre 2003 e 2014

Contact Info

Product

Resources

About